ALK and neoplasm: Phenotypic transformation represents a critical mechanism of resistance to ALK inhibitors, characterized by tumor cells undergoing lineage reprogramming to shift from an ALK-dependent phenotype to alternative cellular states, thereby evading the selective pressure imposed by targeted therapy [61].